214 related articles for article (PubMed ID: 36846854)
1. Recent advances in oridonin derivatives with anticancer activity.
Sobral PJM; Vicente ATS; Salvador JAR
Front Chem; 2023; 11():1066280. PubMed ID: 36846854
[TBL] [Abstract][Full Text] [Related]
2. Chemical proteomics reveals HSP70 1A as a target for the anticancer diterpene oridonin in Jurkat cells.
Dal Piaz F; Cotugno R; Lepore L; Vassallo A; Malafronte N; Lauro G; Bifulco G; Belisario MA; De Tommasi N
J Proteomics; 2013 Apr; 82():14-26. PubMed ID: 23416714
[TBL] [Abstract][Full Text] [Related]
3. Discovery and development of natural product oridonin-inspired anticancer agents.
Ding Y; Ding C; Ye N; Liu Z; Wold EA; Chen H; Wild C; Shen Q; Zhou J
Eur J Med Chem; 2016 Oct; 122():102-117. PubMed ID: 27344488
[TBL] [Abstract][Full Text] [Related]
4. The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens, on tumor cells of different lineage.
Chen S; Gao J; Halicka HD; Huang X; Traganos F; Darzynkiewicz Z
Int J Oncol; 2005 Mar; 26(3):579-88. PubMed ID: 15703811
[TBL] [Abstract][Full Text] [Related]
5. Ent-kaurane diterpenoids from Rabdosia rubescens and their cytotoxic effects on human cancer cell lines.
Bai N; He K; Zhou Z; Tsai ML; Zhang L; Quan Z; Shao X; Pan MH; Ho CT
Planta Med; 2010 Feb; 76(2):140-5. PubMed ID: 19653147
[TBL] [Abstract][Full Text] [Related]
6. Solubility and Bioavailability Enhancement of Oridonin: A Review.
Zhang Y; Wang S; Dai M; Nai J; Zhu L; Sheng H
Molecules; 2020 Jan; 25(2):. PubMed ID: 31947574
[TBL] [Abstract][Full Text] [Related]
7. Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies.
Xu S; Wang G; Lin Y; Zhang Y; Pei L; Yao H; Hu M; Qiu Y; Huang Z; Zhang Y; Xu J
Bioorg Med Chem Lett; 2016 Jun; 26(12):2795-2800. PubMed ID: 27158140
[TBL] [Abstract][Full Text] [Related]
8. Differential control of growth, cell cycle progression, and expression of NF-kappaB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the chinese herb Rabdosia rubescens.
Hsieh TC; Wijeratne EK; Liang JY; Gunatilaka AL; Wu JM
Biochem Biophys Res Commun; 2005 Nov; 337(1):224-31. PubMed ID: 16176802
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of oridonin derivatives as cytotoxic agents.
Zhao CL; Zhang CY; Yang XM; Lam KH; Xia YX; Du YX; Pan LT; Zhang HJ
Nat Prod Res; 2023 Oct; ():1-9. PubMed ID: 37902442
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of Oridonin Derivatives via Mizoroki-Heck Reaction and Click Chemistry for Cytotoxic Activity.
Hou W; Fan Q; Su L; Xu H
Anticancer Agents Med Chem; 2019; 19(7):935-947. PubMed ID: 30657049
[TBL] [Abstract][Full Text] [Related]
11. Recent Development of Oridonin Derivatives with Diverse Pharmacological Activities.
Cheng W; Huang C; Ma W; Tian X; Zhang X
Mini Rev Med Chem; 2019; 19(2):114-124. PubMed ID: 28425866
[TBL] [Abstract][Full Text] [Related]
12. The conversion of oridonin to spirolactone-type or enmein-type diterpenoid: synthesis and biological evaluation of ent-6,7-seco-oridonin derivatives as novel potential anticancer agents.
Wang L; Li D; Xu S; Cai H; Yao H; Zhang Y; Jiang J; Xu J
Eur J Med Chem; 2012 Jun; 52():242-50. PubMed ID: 22483090
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the molecular basis of anti-neoplastic mechanisms of oridonin.
Tian W; Chen SY
Chin J Integr Med; 2013 Apr; 19(4):315-20. PubMed ID: 23546635
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of caspase-9 by oridonin, a diterpenoid isolated from Rabdosia rubescens, augments apoptosis in human laryngeal cancer cells.
Kang N; Cao SJ; Zhou Y; He H; Tashiro S; Onodera S; Qiu F; Ikejima T
Int J Oncol; 2015 Dec; 47(6):2045-56. PubMed ID: 26648189
[TBL] [Abstract][Full Text] [Related]
15. Molecular Insight in the Multifunctional Effects of Oridonin.
Owona BA; Schluesener HJ
Drugs R D; 2015 Sep; 15(3):233-44. PubMed ID: 26290464
[TBL] [Abstract][Full Text] [Related]
16. The anticancer effect of oridonin is mediated by fatty acid synthase suppression in human colorectal cancer cells.
Kwan HY; Yang Z; Fong WF; Hu YM; Yu ZL; Hsiao WL
J Gastroenterol; 2013 Feb; 48(2):182-92. PubMed ID: 22722903
[TBL] [Abstract][Full Text] [Related]
17. Oridonin exerts anticancer effect on osteosarcoma by activating PPAR-γ and inhibiting Nrf2 pathway.
Lu Y; Sun Y; Zhu J; Yu L; Jiang X; Zhang J; Dong X; Ma B; Zhang Q
Cell Death Dis; 2018 Jan; 9(1):15. PubMed ID: 29323103
[TBL] [Abstract][Full Text] [Related]
18. Oridonin derivatives as potential anticancer drug candidates triggering apoptosis through mitochondrial pathway in the liver cancer cells.
Luo D; Yi Y; Peng K; Liu T; Yang J; Liu S; Zhao W; Qu X; Yu W; Gu Y; Wan S
Eur J Med Chem; 2019 Sep; 178():365-379. PubMed ID: 31200238
[TBL] [Abstract][Full Text] [Related]
19. Oridonin inhibits oral cancer growth and PI3K/Akt signaling pathway.
Yang J; Ren X; Zhang L; Li Y; Cheng B; Xia J
Biomed Pharmacother; 2018 Apr; 100():226-232. PubMed ID: 29432993
[TBL] [Abstract][Full Text] [Related]
20. Oridonin inhibits mTOR signaling and the growth of lung cancer tumors.
Wang YY; Lv YF; Lu L; Cai L
Anticancer Drugs; 2014 Nov; 25(10):1192-200. PubMed ID: 25075795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
